# Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study

> **NCT06336174** · — · RECRUITING · sponsor: **Anhui Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Intracranial Atherosclerosis
- Cognitive Impairment
- Cerebrovascular Event

## Interventions

- **DRUG:** Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin
- **PROCEDURE:** Endovascular therapy,Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin

## Key facts

- **NCT ID:** NCT06336174
- **Lead sponsor:** Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06336174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06336174, "Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06336174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
